Please login to the form below

Not currently logged in
Email:
Password:

pharmacovigilance

This page shows the latest pharmacovigilance news and features for those working in and with pharma, biotech and healthcare.

No deal Brexit would see UK miss out on ‘safest medicines system in the world’

No deal Brexit would see UK miss out on ‘safest medicines system in the world’

Questions also remain about the UK’s continued access to other important European databases, including EudraCT the European Clinical Trials Database and the EudraVigilance pharmacovigilance system which flags medicines safety issues.

Latest news

More from news
Approximately 18 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • Five questions guiding the way to actual patient-centricity Five questions guiding the way to actual patient-centricity

    We worry about the effort real patients might make, the risks of social media, pharmacovigilance, off-label questions and a minefield of legal requirements. ... In the right environment, their influence is most notable, and third-party providers can

  • A critical juncture for clinical data management A critical juncture for clinical data management

    The top five most commonly used applications include electronic data capture (EDC) with 100% usage, randomisation and trial-supply management applications with 77% usage, both safety/pharmacovigilance and electronic master file

  • A new era of smart pharma A new era of smart pharma

    How smarter pharmaceuticals and pharmacovigilance are transforming healthcare. The pharmaceutical industry is undergoing an evolution as new technologies disrupt the industry. ... SAEs). It is in this area that pharmacovigilance, the science relating to

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    EMA guidance in recent years has touched on the role of genetics in pharmacovigilance and the importance of being able to identify patient populations with increased sensitivity to medicines.

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    It has established a pharmacovigilance centre of excellence to collect web and social data for the aforementioned purposes. ... Is head of the pharmacovigilance advisory and medical affairs practice at ProductLife Group.

More from intelligence
Approximately 3 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics